This article was originally published in The Gray Sheet
Executive SummaryFirm is developing automated FISH (fluorescence in situ hybridization) gene-probe technology instrument in conjunction with Mercer Scientific International, Downers Grove, Illinois-based Vysis reports Oct. 29. Slated for release in the first quarter of 1999, the system will consist of a re-engineered version of an existing Carl Zeiss automated slide stainer. Under two separate deals, Mercer assumes manufacturing responsibilities while Carl Zeiss agrees to distribute the system and provide customer maintenance and service
You may also be interested in...
All medtech in Brazil will soon be subject to standardized industrial tariffs and development-related fiscal incentives, following a reform of rules relating to ICT across all industries.